Home Cart Sign in  
Chemical Structure| 79055-68-8 Chemical Structure| 79055-68-8

Structure of D-AP5
CAS No.: 79055-68-8

Chemical Structure| 79055-68-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

D-AP5 (D-APV) is a selective and competitive NMDA receptor antagonist with a Kd of 1.4 μM. D-AP5 inhibits glutamate binding at the NMDA receptor's glutamate site.

Synonyms: D-APV; D-2-Amino-5-phosphonovaleric acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of D-AP5

CAS No. :79055-68-8
Formula : C5H12NO5P
M.W : 197.13
SMILES Code : N[C@H](CCCP(O)(O)=O)C(O)=O
Synonyms :
D-APV; D-2-Amino-5-phosphonovaleric acid
MDL No. :MFCD00078839
InChI Key :VOROEQBFPPIACJ-SCSAIBSYSA-N
Pubchem ID :135342

Safety of D-AP5

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse cerebral artery endothelial cells 10 µM 10 minutes D-AP5 significantly prevented the NMDA-induced increase in NMDAR sparklets, indicating that D-AP5 inhibits Ca2+ signaling by blocking the glutamate binding site of NMDAR. PMC8721780
Cortical wedges 3.7 ± 0.32 μM 15-20 minutes D-AP5 exhibited a selective reduction of NMDA-induced depolarization in cortical wedges with little or no effect on responses to quisqualate or kainate. PMC1854208
mouse motor cortex slices 100μM 25 minutes D-AP5 facilitated uniform DCS-LTD across the cortical thickness, abolishing DCS-LTP in deep layers PMC10675838

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice mouse kainic acid seizure model intraperitoneal injection 300μM single dose, 60 minutes duration D-AP5 abolished DCS-LTP in deep layers, enhancing the uniformity of DCS-LTD PMC10675838
Rats Spinal and brainstem neurones Intravenous injection 50-100 mg/kg Single injection, effects lasted more than 6 hours D-AP5, administered intravenously, selectively reduced NMDA-induced excitation in rat spinal and brainstem neurones, with effects lasting more than 6 hours. PMC1854208
Mice C57bl6/J mice In vitro perfusion 10 mmol/L Single administration, lasting 10 minutes D-AP5 significantly blunted NMDA-induced dilation of PComA and parenchymal arterioles, indicating that D-AP5 attenuates vasodilation by inhibiting NMDAR in endothelial cells. PMC8721780
C57BL/6 mice Cecal ligation puncture (CLP)-induced sepsis model Bilateral injection 1 μg/μl Single injection, lasting 30 minutes D-AP5 significantly prevented CNO-induced memory consolidation and improved cognitive dysfunction in septic mice. PMC9804045

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.07mL

1.01mL

0.51mL

25.36mL

5.07mL

2.54mL

50.73mL

10.15mL

5.07mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories